These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21683840)

  • 41. Late Cardiac Rupture after Amplatzer Septal Occluder Implantation.
    Arnaz A; Turkekul Y; Yalcinbas Y; Saygili A; Sarioglu T
    Tex Heart Inst J; 2016 Dec; 43(6):541-542. PubMed ID: 28100979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early experience with a simplified technique for transcatheter closure of the patent foramen ovale.
    Kutty S; Nykanen DG; Zahn EM
    Heart Lung Circ; 2009 Dec; 18(6):384-7. PubMed ID: 19783211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcatheter closure of perimembranous VSD: symmetric and asymmetric occluders.
    Lucas V
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):91. PubMed ID: 21181972
    [No Abstract]   [Full Text] [Related]  

  • 44. Which patients might be suitable for a septal occluder device closure of postinfarction ventricular septal rupture rather than immediate surgery?
    Attia R; Blauth C
    Interact Cardiovasc Thorac Surg; 2010 Nov; 11(5):626-9. PubMed ID: 20621996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implantation of a second Amplatzer device to eliminate residual shunt after transcatheter patent foramen ovale closure.
    Chessa M; Citro R; Butera G; Provenza G; Bossone E; Carminati M
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):736-7. PubMed ID: 19483639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late left atrial thrombosis of an Amplatzer patent foramen ovale occluder.
    Klotz S; Gebhard M; Sievers HH
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1270-1. PubMed ID: 21724200
    [No Abstract]   [Full Text] [Related]  

  • 47. Closure of the patent foramen ovale with dedicated Amplatzer occluders: Closing in on a mechanical vaccination.
    Meier B
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):80-1. PubMed ID: 18561159
    [No Abstract]   [Full Text] [Related]  

  • 48. Late thrombus formation on the Helex septal occluder after double-lung transplant.
    Zaidi AN; Cheatham JP; Galantowicz M; Astor T; Kovalchin JP
    J Heart Lung Transplant; 2010 Jul; 29(7):814-6. PubMed ID: 20382035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Minimal invasive retrieval of dislodged Amplatzer occluder with subsequent impediments.
    Born P; Eckstein F; Buser P; Reuthebuch O
    Thorac Cardiovasc Surg; 2013 Jun; 61(4):330-2. PubMed ID: 22535671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term follow up of secundum atrial septal defect closure with the amplatzer septal occluder.
    Knepp MD; Rocchini AP; Lloyd TR; Aiyagari RM
    Congenit Heart Dis; 2010; 5(1):32-7. PubMed ID: 20136855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous rescue of left ventricular embolized amplatzer septal occluder device.
    Balbi M; Pongiglione G; Bezante GP
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):559-62. PubMed ID: 18819121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The patent ductus arteriosus-multiple defects and a moving target.
    Mullins CE
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):703-4. PubMed ID: 20976751
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunohistochemical characterization of neotissues and tissue reactions to septal defect-occlusion devices.
    Foth R; Quentin T; Michel-Behnke I; Vogt M; Kriebel T; Kreischer A; Ruschewski W; Paul T; Sigler M
    Circ Cardiovasc Interv; 2009 Apr; 2(2):90-6. PubMed ID: 20031701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
    [No Abstract]   [Full Text] [Related]  

  • 55. Erosions, erosions, and erosions! Device closure of atrial septal defects: how safe is safe?
    Diab K; Kenny D; Hijazi ZM
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):168-74. PubMed ID: 22718680
    [No Abstract]   [Full Text] [Related]  

  • 56. Severe allergic dermatitis after closure of foramen ovale with Amplatzer occluder.
    Belohlavek J; Belohlavkova S; Hlubocky J; Mrazek V; Linhart A; Podzimek S
    Ann Thorac Surg; 2013 Sep; 96(3):e57-9. PubMed ID: 23992730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Late cardiac perforation after transcatheter closure of patent foramen ovale mimicking acute type a aortic dissection.
    Girdauskas E; Diab M; Secknus MA; Borger MA; Kuntze T
    Ann Thorac Surg; 2010 May; 89(5):1649-51. PubMed ID: 20417804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catch me if you can: transseptal retrieval of a dislodged left atrial appendage occluder.
    Perrotta L; Bordignon S; Fürnkranz A; Chun JK; Eggebrecht H; Schmidt B
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):e64. PubMed ID: 23962866
    [No Abstract]   [Full Text] [Related]  

  • 59. Transcatheter device closure of atrial septal defects: a safety review.
    Moore J; Hegde S; El-Said H; Beekman R; Benson L; Bergersen L; Holzer R; Jenkins K; Ringel R; Rome J; Vincent R; Martin G;
    JACC Cardiovasc Interv; 2013 May; 6(5):433-42. PubMed ID: 23702008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac perforation 6 years following the implantation of an Amplatzer septal occluder.
    Agematsu K; Okamura T; Takiguchi Y; Harada Y
    J Card Surg; 2018 Feb; 33(2):105-106. PubMed ID: 29460301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.